- Tuesday, February 10, 2026
- India +91 7982732466
- U.S +1 217 953 4020
- Info@Shingetsuresearch.com
Global In-Vitro Diagnostics Market- By Product Type (Reagents, Instruments, and Software & Services), By Technique (Immunodiagnostics, Hematology, Molecular Diagnostics, Tissue Diagnostics, Clinical Chemistry, and Other IVD Techniques), By Application (Infectious Diseases, Cancer, Cardiac Diseases, Immune System Disorders, Nephrological Diseases, Gastrointestinal Diseases, and Other Indications), and By End User (Standalone Laboratory, Hospitals, Academic & Medical Schools, Point of Care Testing, and Others)and By Region (North America, Europe, Asia Pacific, South America, and Middle East, & Africa)- Global forecast from 2022-2030.
Global In-Vitro Diagnostics Market Overview:
The global In-Vitro Diagnostics market is estimated to reach USD 135 billion by 2030, growing at a CAGR of 4.5% during the forecast period of 2022-2030. It was valued at USD 93 billion in 2022. In-vitro diagnostics or IVD refers to products and clinical functions obtained by testing human samples (various body fluids, cells, tissue samples, etc.) outside the human body to collect clinical diagnostic information to determine the disease. It involves molecular biology, genetic diagnostics, translational medicine, and other disciplines.Global In-Vitro Diagnostics Market Insights
The continuous growth of the worldwide population base and the increasing incidence of chronic diseases and tumors have become the driving forces for the continued development of the global IVD market. Moreover, the in-vitro diagnostic industry is a branch of the medical device industry. It is a multidisciplinary, knowledge-intensive, and capital-intensive high-tech sector. It is a combination of traditional manufacturing and high-tech technologies such as biomedical engineering, electronic information technology, and the modern medical imaging technology industry. Additionally, In-vitro diagnosis plays a significant role in the entire process of disease prevention, diagnosis, monitoring, and guiding treatment. It is an indispensable tool for modern disease and health management. With the rapid development of various new technologies and the gradual improvement of most national medical security policies, the IVD industry has developed rapidly. It has become one of the most vital and fastest-growing sectors in the pharmaceutical market. Furthermore, the global in-vitro diagnostic market is propelling due to factors such as an aging population, increasing insurance coverage, rising expenditure, and high income. Also, the out-patient diagnosis industry has become one of the most dynamic and fastest-growing industries. After disease prevention, diagnosis, and recovery judgment, therapeutic drug screening, health assessment, and heredity prediction are playing an increasingly important role.Growth Driver
Informatization and Digitalization
After the future of cloud intelligence, IVD companies will not sell products and services but sell the cloud. Products and services will only be terminal data collectors. In different application scenarios, these collected data will be transferred to the cloud and become precious data assets. The future industry leaders will integrate global industrial resources through informatization and digitalization.Change in Technology
The market share of immunodiagnostics, microbiology, blood glucose testing, and coagulation testing has changed. In addition to it, the proportion of biochemical diagnostics has dropped significantly, and the percentage of emerging technologies in molecular diagnostics and POCT has increased substantially.By Product Segmental Analysis
Based on the product, the global In-Vitro Diagnostics market segmented into Reagents, Instruments, and Software & Services. The instrument’s product segment captures the largest share in the recent market. However, the reagents product segment expected to dominate the market in the forecast period from 2022-2030. It is mainly owing to the increasing number of IVD tests worldwide, which rise in demand for reagents. In addition to it, the increased number of chronic diseases and the adoption of self-test and point of care devices will fuel the market demand for the reagents in the market.By Technique Segmental Analysis
Based on the technique, the global In-Vitro Diagnostics market classified into Immunodiagnostics, Hematology, Molecular Diagnostics, Tissue Diagnostics, Clinical Chemistry, and Other IVD Techniques. The Immunodiagnostics technique segment is currently in the mainstream and captures the largest share in the global in-vitro diagnostics market. It is mainly owing to rising cases of chronic and infectious diseases, coupled with increasing demand for early detection of the disease, which will fuel the IVD market. Moreover, molecular diagnostics has increased, and it is likely to catch up in the future. Besides, application scenarios such as prenatal diagnosis, tumor genetic testing, and personalized medicine will become the mainstream trend in the future, and the demand will be quickly released.By Application Segmental Analysis
Based on the application, the global In-Vitro Diagnostics market aggregated into Infectious Diseases, Cancer, Cardiac Diseases, Immune System Disorders, Nephrological Diseases, Gastrointestinal Diseases, and Other Indications. Infectious diseases have captured the market’s largest share as it is owing to the emerging geriatric population increased the cases of cardiovascular diseases. Moreover, the oncology segment will bolster its market share in the forecast period. Due to propelling demand for non-invasive instruments, home care kits for diagnosis of colon cancer are rising market share for global In-vitro diagnostics.By End-use Segmental Analysis
Based on End-use, the global In-Vitro Diagnostics market classified into Standalone laboratories, Hospitals, Academic & Medical Schools, Point of Care Testing, and Others. The standalone laboratory segment has dominated the largest market share in the global in-vitro diagnostics market mainly due to rising demand for glucose meters, pregnancy kits, biosensors for quick and accurate results. However, POCT will bolster its market demand owing to POCT detection short time, portability of instrument, and the operator does not need too much professional training to get started quickly. Thus, it helps in increasing the demand for POCT in the forecast period from 2022-2030.By Region Segmental Analysis
Based on geography, the global In-Vitro Diagnostics market segmented into North America, Europe, Asia Pacific, South America, and Middle East & Africa. North America expected to hold the largest share of the global in-vitro diagnostics market. The rising cases of infectious diseases, emerging geriatric population, and advancement in diagnostic instruments and adoption of the advance diagnostic technique are fueling the market demand for the global in-vitro diagnostics market.Competitor Analysis
Companies such as Abbott Laboratories, Becton, Dickinson and Company, bioMérieux SA, Bio-Rad Laboratories, Inc., Danaher Corporation (Beckman Coulter, Inc.), F. Hoffmann-La Roche Ltd., Johnson & Johnson, QIAGEN N.V., Sysmex Corporation, and Thermo Fisher Scientific, Inc. and others are key players in the global In-Vitro Diagnostics market.Key Stakeholders
- Market research and consulting firms
- Industry associations
- Global In-Vitro Diagnostics manufacturing companies
- Research organizations and consulting companies’ clinical In-Vitro Diagnostics
- Regulatory bodies
- In November 2023, Veracyte entered Illumina to develop molecular tests for decentralized IVD applications. Firms are focusing on the growth of Prosigna breast cancer and Percepta nasal swab tests of Veracyte
- In October 2023, Promega Corporation declared its plan to develop and commercialize companion diagnostics kits with GSK Plc to identify cancer patients with MSI-H solid tumors
The objective of the Research
- Market modeling starts with identifying a target market where historical data exists. A Market can include prediction problems, economic factors, analyzing customer behavior, and identifying new patterns from past events, which helps our client to have deep dive into the market.
- Product analysis involves steps such as examining product features, costs, availability, quality, and other aspects. Product analysis is conducted to understand potential buyers and measure competition in the market.
- Market Trend and Economic Factors Analysis helps in assessing potential changes to an economy’s inflation rate, taxes, interest rates, exchange rates, trading regulations, and excise duties that can or have a major effect on the target market.
- Market Segmental Analysis defines in-depth scenario of the target market by the process of grouping consumers into naturally existing created segments of consumers who share similar product preferences or characteristics
- The geographical mapping approach helps our clients to understand national or international markets because different consumers in different regions have different needs wants, and cultural characteristics that can be specifically targeted.
Market Modelling
By Product Type- Reagents
- Instruments
- Software & Services
- Immunodiagnostics
- Enzyme-Linked Immunosorbent Assay (ELISA)
- Chemiluminescence Immunoassays (CLIAS)
- Fluorescence Immunoassays (FIAS)
- Colorimetric Immunoassays (CIS)
- Rapid Tests
- Enzyme-Linked ImmunoSpot Assays (ELISPOT)
- Radioimmunoassay
- Western Blot
- Hematology
- Molecular Diagnostics
- Polymerase Chain Reaction (PCR)
- Isothermal Nucleic Acid Amplification Technology (INAAT)
- Hybridization
- DNA Diagnostics
- Microarrays
- Others
- Tissue Diagnostics
- Clinical Chemistry
- Basic Metabolic Panel
- Liver Panel
- Lipid Profile
- Thyroid Function Panel
- Renal Profile
- Electrolyte Panel
- Specialty Chemicals
- Other IVD Techniques
- Infectious Diseases
- Cancer
- Cardiac Diseases
- Immune System Disorders
- Nephrological Diseases
- Gastrointestinal Diseases
- Other Indications
- Standalone Laboratory
- Hospitals
- Academic & Medical Schools
- Point of Care Testing
- Others
- Europe
- North America
- Asia Pacific
- South America
- Middle East & Africa
More Related Reports:
Hydrophobic Interaction Chromatography Market
Perimeter Intrusion Detection Systems Market
Precious Metal Catalysts Market
Report Content
- Research Strategic Development
1.1. Market Modelling
1.2. Product Analysis
1.3. Market Trend and Economic Factors Analysis
1.4. Market Segmental Analysis
1.5. Geographical Mapping
1.6. Country Wise Segregation
- Research Methodology
2.1. Identification of Target Market
2.2. Data Acquisition
2.3. Refining of Data/ Data Transformations
2.4. Data Validation through Primary Techniques
2.5. Exploratory Data Analysis
2.6. Graphical Techniques/Analysis
2.7. Quantitative Techniques/Analysis
2.8. Visual Result/Presentation
- Executive Summary
- Market Insights
4.1. Supply Chain Analysis
4.2. Economic Factor Analysis
4.2.1. Drivers
4.2.2. Trends
4.2.3. Opportunities
4.2.4. Challenges
4.3. Technological Landscape
4.4. Competitors & Product Analysis
4.5. Regulatory Framework
4.6. Company market share analysis, 2022
4.7. Porter’s Five forces analysis
4.8. Price point analysis
4.9. New Investment Analysis
4.10. PESTEL Analysis
- Global In-Vitro Diagnostics Market Overview
5.1. Market Size & Forecast,2017-2030
5.1.1. Demand
5.1.1.1. By Value (USD Billion)
5.2. Market Share & Forecast, 2017-2030
5.2.1. By Product Type
5.2.1.1. Reagents
5.2.1.2. Instruments
5.2.1.3. Software & Services
5.2.2. By Technique
5.2.2.1. Immunodiagnostics
5.2.2.1.1. Enzyme-Linked Immunosorbent Assay (ELISA)
5.2.2.1.2. Chemiluminescence Immunoassays (CLIAS)
5.2.2.1.3. Fluorescence Immunoassays (FIAS)
5.2.2.1.4. Colorimetric Immunoassays (CIS)
5.2.2.1.5. Rapid Tests
5.2.2.2. Enzyme-Linked ImmunoSpot Assays (ELISPOT)
5.2.2.2.1. Radioimmunoassay
5.2.2.2.2. Western Blot
5.2.2.2.3. Hematology
5.2.2.2.4. Molecular Diagnostics
5.2.2.3. Polymerase Chain Reaction (PCR)
5.2.2.4. Isothermal Nucleic Acid Amplification Technology (INAAT)
5.2.2.5. Hybridization
5.2.2.6. DNA Diagnostics
5.2.2.7. Microarrays
5.2.2.8. Others
5.2.2.9. Tissue Diagnostics
5.2.2.10. Clinical Chemistry
5.2.2.10.1. Basic Metabolic Panel
5.2.2.10.2. Liver Panel
5.2.2.10.3. Lipid Profile
5.2.2.10.4. Thyroid Function Panel
5.2.2.10.5. Renal Profile
5.2.2.10.6. Electrolyte Panel
5.2.2.10.7. Specialty Chemicals
5.2.2.11. Other IVD Techniques
5.2.3. By Application
5.2.3.1. Infectious Diseases
5.2.3.2. Cancer
5.2.3.3. Cardiac Diseases
5.2.3.4. Immune System Disorders
5.2.3.5. Nephrological Diseases
5.2.3.6. Gastrointestinal Diseases
5.2.3.7. Other Indications
5.2.4. By End-User
5.2.4.1. Standalone Laboratory
5.2.4.2. Hospitals
5.2.4.3. Academic & Medical Schools
5.2.4.4. Point of Care Testing
5.2.4.5. Others
5.2.5. By Region
5.2.5.1. North America
5.2.5.2. Europe
5.2.5.3. Asia-Pacific
5.2.5.4. South America
5.2.5.5. The Middle East & Africa
- North America In-Vitro Diagnostics Market Overview
6.1. North America In-Vitro Diagnostics Market Size & Forecast,2017-2030
6.1.1. Demand
6.1.1.1. By Value (USD Billion)
6.2. Market Share & Forecast, 2017-2030
6.2.1. By Product Type
6.2.1.1. Reagents
6.2.1.2. Instruments
6.2.1.3. Software & Services
6.2.2. By Technique
6.2.2.1. Immunodiagnostics
6.2.2.1.1. Enzyme-Linked Immunosorbent Assay (ELISA)
6.2.2.1.2. Chemiluminescence Immunoassays (CLIAS)
6.2.2.1.3. Fluorescence Immunoassays (FIAS)
6.2.2.1.4. Colorimetric Immunoassays (CIS)
6.2.2.1.5. Rapid Tests
6.2.2.2. Enzyme-Linked ImmunoSpot Assays (ELISPOT)
6.2.2.2.1. Radioimmunoassay
6.2.2.2.2. Western Blot
6.2.2.2.3. Hematology
6.2.2.2.4. Molecular Diagnostics
6.2.2.3. Polymerase Chain Reaction (PCR)
6.2.2.4. Isothermal Nucleic Acid Amplification Technology (INAAT)
6.2.2.5. Hybridization
6.2.2.6. DNA Diagnostics
6.2.2.7. Microarrays
6.2.2.8. Others
6.2.2.9. Tissue Diagnostics
6.2.2.10. Clinical Chemistry
6.2.2.10.1. Basic Metabolic Panel
6.2.2.10.2. Liver Panel
6.2.2.10.3. Lipid Profile
6.2.2.10.4. Thyroid Function Panel
6.2.2.10.5. Renal Profile
6.2.2.10.6. Electrolyte Panel
6.2.2.10.7. Specialty Chemicals
6.2.2.11. Other IVD Techniques
6.2.3. By Application
6.2.3.1. Infectious Diseases
6.2.3.2. Cancer
6.2.3.3. Cardiac Diseases
6.2.3.4. Immune System Disorders
6.2.3.5. Nephrological Diseases
6.2.3.6. Gastrointestinal Diseases
6.2.3.7. Other Indications
6.2.4. By End-User
6.2.4.1. Standalone Laboratory
6.2.4.2. Hospitals
6.2.4.3. Academic & Medical Schools
6.2.4.4. Point of Care Testing
6.2.4.5. Others
6.2.5. By Country
6.2.5.1. US
6.2.5.2. Canada
6.2.5.3. Mexico
6.2.6. Company Market Share (Top 3-5)
6.2.7. Economic Impact Study on North America In-Vitro Diagnostics Market
- Europe In-Vitro Diagnostics Market Overview
7.1. Europe In-Vitro Diagnostics Market Size & Forecast,2017-2030
7.1.1. Demand
7.1.1.1. By Value (USD Billion)
7.2. Market Share & Forecast, 2017-2030
7.2.1. By Product Type
7.2.1.1. Reagents
7.2.1.2. Instruments
7.2.1.3. Software & Services
7.2.2. By Technique
7.2.2.1. Immunodiagnostics
7.2.2.1.1. Enzyme-Linked Immunosorbent Assay (ELISA)
7.2.2.1.2. Chemiluminescence Immunoassays (CLIAS)
7.2.2.1.3. Fluorescence Immunoassays (FIAS)
7.2.2.1.4. Colorimetric Immunoassays (CIS)
7.2.2.1.5. Rapid Tests
7.2.2.2. Enzyme-Linked ImmunoSpot Assays (ELISPOT)
7.2.2.2.1. Radioimmunoassay
7.2.2.2.2. Western Blot
7.2.2.2.3. Hematology
7.2.2.2.4. Molecular Diagnostics
7.2.2.3. Polymerase Chain Reaction (PCR)
7.2.2.4. Isothermal Nucleic Acid Amplification Technology (INAAT)
7.2.2.5. Hybridization
7.2.2.6. DNA Diagnostics
7.2.2.7. Microarrays
7.2.2.8. Others
7.2.2.9. Tissue Diagnostics
7.2.2.10. Clinical Chemistry
7.2.2.10.1. Basic Metabolic Panel
7.2.2.10.2. Liver Panel
7.2.2.10.3. Lipid Profile
7.2.2.10.4. Thyroid Function Panel
7.2.2.10.5. Renal Profile
7.2.2.10.6. Electrolyte Panel
7.2.2.10.7. Specialty Chemicals
7.2.2.11. Other IVD Techniques
7.2.3. By Application
7.2.3.1. Infectious Diseases
7.2.3.2. Cancer
7.2.3.3. Cardiac Diseases
7.2.3.4. Immune System Disorders
7.2.3.5. Nephrological Diseases
7.2.3.6. Gastrointestinal Diseases
7.2.3.7. Other Indications
7.2.4. By End-User
7.2.4.1. Standalone Laboratory
7.2.4.2. Hospitals
7.2.4.3. Academic & Medical Schools
7.2.4.4. Point of Care Testing
7.2.4.5. Others
7.2.5. By Country
7.2.5.1. Germany
7.2.5.2. UK
7.2.5.3. France
7.2.5.4. Italy
7.2.5.5. Rest of Europe
7.2.6. Company Market Share (Top 3-5)
7.2.7. Economic Impact Study on Europe In-Vitro Diagnostics Market
- Asia-Pacific In-Vitro Diagnostics Market Overview
8.1. Asia-Pacific In-Vitro Diagnostics Market Size & Forecast,2017-2030
8.1.1. Demand
8.1.1.1. By Value (USD Billion)
8.2. Market Share & Forecast, 2017-2030
8.2.1. By Product Type
8.2.1.1. Reagents
8.2.1.2. Instruments
8.2.1.3. Software & Services
8.2.2. By Technique
8.2.2.1. Immunodiagnostics
8.2.2.1.1. Enzyme-Linked Immunosorbent Assay (ELISA)
8.2.2.1.2. Chemiluminescence Immunoassays (CLIAS)
8.2.2.1.3. Fluorescence Immunoassays (FIAS)
8.2.2.1.4. Colorimetric Immunoassays (CIS)
8.2.2.1.5. Rapid Tests
8.2.2.2. Enzyme-Linked ImmunoSpot Assays (ELISPOT)
8.2.2.2.1. Radioimmunoassay
8.2.2.2.2. Western Blot
8.2.2.2.3. Hematology
8.2.2.2.4. Molecular Diagnostics
8.2.2.3. Polymerase Chain Reaction (PCR)
8.2.2.4. Isothermal Nucleic Acid Amplification Technology (INAAT)
8.2.2.5. Hybridization
8.2.2.6. DNA Diagnostics
8.2.2.7. Microarrays
8.2.2.8. Others
8.2.2.9. Tissue Diagnostics
8.2.2.10. Clinical Chemistry
8.2.2.10.1. Basic Metabolic Panel
8.2.2.10.2. Liver Panel
8.2.2.10.3. Lipid Profile
8.2.2.10.4. Thyroid Function Panel
8.2.2.10.5. Renal Profile
8.2.2.10.6. Electrolyte Panel
8.2.2.10.7. Specialty Chemicals
8.2.2.11. Other IVD Techniques
8.2.3. By Application
8.2.3.1. Infectious Diseases
8.2.3.2. Cancer
8.2.3.3. Cardiac Diseases
8.2.3.4. Immune System Disorders
8.2.3.5. Nephrological Diseases
8.2.3.6. Gastrointestinal Diseases
8.2.3.7. Other Indications
8.2.4. By End-User
8.2.4.1. Standalone Laboratory
8.2.4.2. Hospitals
8.2.4.3. Academic & Medical Schools
8.2.4.4. Point of Care Testing
8.2.4.5. Others
8.2.5. By Country
8.2.5.1. India
8.2.5.2. Japan
8.2.5.3. Australia
8.2.5.4. Rest of Asia Pacific
8.2.6. Company Market Share (Top 3-5)
8.2.7. Economic Impact Study on Asia Pacific In-Vitro Diagnostics Market
- South America In-Vitro Diagnostics Market Overview
9.1. South America In-Vitro Diagnostics Market Size & Forecast,2017-2030
9.1.1. Demand
9.1.1.1. By Value (USD Billion)
9.2. Market Share & Forecast, 2017-2030
9.2.1. By Product Type
9.2.1.1. Reagents
9.2.1.2. Instruments
9.2.1.3. Software & Services
9.2.2. By Technique
9.2.2.1. Immunodiagnostics
9.2.2.1.1. Enzyme-Linked Immunosorbent Assay (ELISA)
9.2.2.1.2. Chemiluminescence Immunoassays (CLIAS)
9.2.2.1.3. Fluorescence Immunoassays (FIAS)
9.2.2.1.4. Colorimetric Immunoassays (CIS)
9.2.2.1.5. Rapid Tests
9.2.2.2. Enzyme-Linked ImmunoSpot Assays (ELISPOT)
9.2.2.2.1. Radioimmunoassay
9.2.2.2.2. Western Blot
9.2.2.2.3. Hematology
9.2.2.2.4. Molecular Diagnostics
9.2.2.3. Polymerase Chain Reaction (PCR)
9.2.2.4. Isothermal Nucleic Acid Amplification Technology (INAAT)
9.2.2.5. Hybridization
9.2.2.6. DNA Diagnostics
9.2.2.7. Microarrays
9.2.2.8. Others
9.2.2.9. Tissue Diagnostics
9.2.2.10. Clinical Chemistry
9.2.2.10.1. Basic Metabolic Panel
9.2.2.10.2. Liver Panel
9.2.2.10.3. Lipid Profile
9.2.2.10.4. Thyroid Function Panel
9.2.2.10.5. Renal Profile
9.2.2.10.6. Electrolyte Panel
9.2.2.10.7. Specialty Chemicals
9.2.2.11. Other IVD Techniques
9.2.3. By Application
9.2.3.1. Infectious Diseases
9.2.3.2. Cancer
9.2.3.3. Cardiac Diseases
9.2.3.4. Immune System Disorders
9.2.3.5. Nephrological Diseases
9.2.3.6. Gastrointestinal Diseases
9.2.3.7. Other Indications
9.2.4. By End-User
9.2.4.1. Standalone Laboratory
9.2.4.2. Hospitals
9.2.4.3. Academic & Medical Schools
9.2.4.4. Point of Care Testing
9.2.4.5. Others
9.2.5. By Country
9.2.5.1. Brazil
9.2.5.2. Argentina
9.2.5.3. Rest of South America
9.2.6. Company Market Share (Top 3-5)
9.2.7. Economic Impact Study on South America In-Vitro Diagnostics Market
- The Middle East & Africa In-Vitro Diagnostics Market Overview
10.1. The Middle East & Africa In-Vitro Diagnostics Market Size & Forecast,2017-2030
10.1.1. Demand
10.1.1.1. By Value (USD Billion)
10.2. Market Share & Forecast, 2017-2030
10.2.1. By Product Type
10.2.1.1. Reagents
10.2.1.2. Instruments
10.2.1.3. Software & Services
10.2.2. By Technique
10.2.2.1. Immunodiagnostics
10.2.2.1.1. Enzyme-Linked Immunosorbent Assay (ELISA)
10.2.2.1.2. Chemiluminescence Immunoassays (CLIAS)
10.2.2.1.3. Fluorescence Immunoassays (FIAS)
10.2.2.1.4. Colorimetric Immunoassays (CIS)
10.2.2.1.5. Rapid Tests
10.2.2.2. Enzyme-Linked ImmunoSpot Assays (ELISPOT)
10.2.2.2.1. Radioimmunoassay
10.2.2.2.2. Western Blot
10.2.2.2.3. Hematology
10.2.2.2.4. Molecular Diagnostics
10.2.2.3. Polymerase Chain Reaction (PCR)
10.2.2.4. Isothermal Nucleic Acid Amplification Technology (INAAT)
10.2.2.5. Hybridization
10.2.2.6. DNA Diagnostics
10.2.2.7. Microarrays
10.2.2.8. Others
10.2.2.9. Tissue Diagnostics
10.2.2.10. Clinical Chemistry
10.2.2.10.1. Basic Metabolic Panel
10.2.2.10.2. Liver Panel
10.2.2.10.3. Lipid Profile
10.2.2.10.4. Thyroid Function Panel
10.2.2.10.5. Renal Profile
10.2.2.10.6. Electrolyte Panel
10.2.2.10.7. Specialty Chemicals
10.2.2.11. Other IVD Techniques
10.2.3. By Application
10.2.3.1. Infectious Diseases
10.2.3.2. Cancer
10.2.3.3. Cardiac Diseases
10.2.3.4. Immune System Disorders
10.2.3.5. Nephrological Diseases
10.2.3.6. Gastrointestinal Diseases
10.2.3.7. Other Indications
10.2.4. By End-User
10.2.4.1. Standalone Laboratory
10.2.4.2. Hospitals
10.2.4.3. Academic & Medical Schools
10.2.4.4. Point of Care Testing
10.2.4.5. Others
10.2.5. By Country
10.2.5.1. Saudi Arabia
10.2.5.2. UAE
10.2.5.3. South Africa
10.2.5.4. Rest of the Middle East & Africa
10.2.6. Company Market Share (Top 3-5)
10.2.7. Economic Impact Study on Middle East & Africa In-Vitro Diagnostics Market
- Competitor Analysis
11.1. Company Description
11.2. Financial Analysis
11.3. Key Products
11.4. Key Management Personnel
11.5. Contact Address
11.6. SWOT Analysis
11.7. Company Profile
11.7.1. Abbott Laboratories
11.7.2. Becton, Dickinson and Company
11.7.3. bioMérieux SA
11.7.4. Bio-Rad Laboratories, Inc.
11.7.5. Danaher Corporation (Beckman Coulter, Inc.)
11.7.6. Hoffmann-La Roche Ltd.
11.7.7. Johnson & Johnson
11.7.8. QIAGEN N.V.
11.7.9. Sysmex Corporation
11.7.10. Thermo Fisher Scientific, Inc
11.7.11. Other Prominent Players
Frequently Asked Questions (FAQ)
The global In-Vitro Diagnostics market is estimated to reach USD 135 billion by 2030, growing at a CAGR of 4.5% during the forecast period of 2022-2030. It was valued at USD 93 billion in 2022.
The continuous growth of the worldwide population base and the increasing incidence of chronic diseases and tumors have become the driving forces for the continued development of the global IVD market.
In-vitro diagnostics or IVD refers to products and clinical functions obtained by testing human samples (various body fluids, cells, tissue samples, etc.) outside the human body to collect clinical diagnostic information to determine the disease.
Companies such as Abbott Laboratories, Becton, Dickinson and Company, bioMérieux SA, Bio-Rad Laboratories, Inc., Danaher Corporation (Beckman Coulter, Inc.), F. Hoffmann-La Roche Ltd., Johnson & Johnson, QIAGEN N.V., Sysmex Corporation, and Thermo Fisher Scientific, Inc. and others are key players in the global In-Vitro Diagnostics market.
